LEAH Labs provides Car T cells for curing B-cell lymphoma cancer in dogs .
LEAH Labs provides Car T cells for curing B-cell lymphoma cancer in dogs.Scientists at LEAH Labs use precision gene editing to reprogram T immune cells with Chimeric Antigen Receptors (CAR) in order to create CAR T cells that seek out, specifically recognize, and destroy B cell lymphoma without the off-target side effects that come with chemotherapy.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 10, 2022 | Grant | $100K | 1 | — | — | Detail |
May 8, 2020 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
Regenerative Medicine Minnesota | — | Grant |